Emerging drugs for alpha-1-antitrypsin deficiency

Bibliography

• Willemse BW, ten Hacken NH, Rutgers B, Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 2005;26(5):835-45
   PubMed Web of Science ®Google Scholar
• Larson RK, Barman ML, Kueppers F, Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann Intern Med 1970;72(5):627-32
   PubMed Web of Science ®Google Scholar
• Kueppers F, Miller RD, Gordon H, Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977;63(3):336-42
   PubMed Web of Science ®Google Scholar
• Hunninghake GM, Cho MH, Tesfaigzi Y, MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009;361(27):2599-608
   PubMed Web of Science ®Google Scholar
• Laurell C, Eriksson S. The electrophoretic alpha 1-globulin pattern of serum in alpha 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-40
   Web of Science ®Google Scholar
• Eriksson S. Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl 1965;432:1-85
   PubMedGoogle Scholar
• Gross P, Pfitzer EA, Tolker E, Experimental emphysema: its production with papain in normal and silicotic rats. Arch Environ Health 1965;11:50-8
   PubMed Web of Science ®Google Scholar
• Stockley RA. Alpha-1-antitrypsin deficiency. In: Voelkel NF, MacNee W, editors, Chronic obstructive lung diseases 2. BC Decker Inc, Hamilton, Ontario, Canada; 2008. p. 53-62
   Google Scholar
• Dawkins PA, Dawkins CL, Wood AM, Rate of progression of lung function impairment in alpha-1-antitrypsin deficiency. Eur Respir J 2009;33:1338-44
   PubMed Web of Science ®Google Scholar
• Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency 1: epidemiology of alpha1-antitrypsin deficiency. Thorax 2004;59(2):164-9
   PubMed Web of Science ®Google Scholar
• Blanco I, de Serres FJ, Fernandez-Bustillo E, Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries. Eur Respir J 2006;27(1):77-84
   PubMed Web of Science ®Google Scholar
• Silverman EK, Chapman HA, Drazen JM, Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998;157(6 Pt 1):1770-8
   PubMed Web of Science ®Google Scholar
• Janciauskiene SM, Nita IM, Stevens T. Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem 2007;282(12):8573-82
   PubMed Web of Science ®Google Scholar
• Churg A, Wang X, Wang RD, Alpha1-antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages. Am J Respir Cell Mol Biol 2007;7(2):144-51
   Web of Science ®Google Scholar
• Lomas DA, Evans DL, Finch JT, The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992;357(6379):605-7
   PubMed Web of Science ®Google Scholar
• Parmar JS, Mahadeva R, Reed BJ, Polymers of alpha (1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol 2002;6(6):723-30
   Google Scholar
• Persson C, Subramaniyam D, Stevens T, Do native and polymeric alpha1-antitrypsin activate human neutrophils in vitro? Chest 2006;129(6):1683-92
   PubMed Web of Science ®Google Scholar
• Belorgey D, Hagglof P, Karlsson-Li S, Protein misfolding and the serpinopathies. Prion 2007;1(1):15-20
   PubMed Web of Science ®Google Scholar
• Morrison HM, Kramps JA, Burnett D, Lung lavage fluid from patients with alpha1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci 1987;72:373-81
   PubMed Web of Science ®Google Scholar
• Hubbard RC, Fells G, Gadek J, Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 1991;88(3):891-7
   PubMed Web of Science ®Google Scholar
• Kuwahara I, Lillehoj EP, Lu W, Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-kappaB activation via EGFR transactivation in a lung epithelial cell line. Am J Physiol Lung Cell Mol Physiol 2006;291:L407-16
   PubMed Web of Science ®Google Scholar
• Ho SC, Lee KY, Chan YF, Neutrophil elastase represses IL-8/CXCL8 synthesis in human airway smooth muscle cells through induction of NF-kappa B repressing factor. J Immunol 2009;183(1):411-20
   PubMed Web of Science ®Google Scholar
• Liou TG, Campbell EJ. Nonisotropic enzyme – inhibitor interactions: a novel nonoxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry 1995;34(49):16171-7
   PubMed Web of Science ®Google Scholar
• Liou TG, Campbell EJ. Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative mechanism of extracellular proteolytic activity. J Immunol 1996;157(6):2624-31
   PubMed Web of Science ®Google Scholar
• Cepinskas G, Sandig M, Kvietys PR. PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. J Cell Sci 1999;112(Pt 12):1937-45
   PubMed Web of Science ®Google Scholar
• Morrison HM, Welgus HG, Stockley RA, Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity. Am J Respir Cell Mol Biol 1990;2:263-9
   PubMed Web of Science ®Google Scholar
• Fregonese L, Stolk J, Frants RR, Alpha-1 antitrypsin Null mutations and severity of emphysema. Respir Med 2008;102(6):876-84
   PubMed Web of Science ®Google Scholar
• Morse JO, Lebowitz MD, Knudson RJ, Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N Engl J Med 1977;296(21):1190-4
   PubMed Web of Science ®Google Scholar
• Gelb AF, Klein E, Lieberman J. Pulmonary function in nonsmoking subjects with alpha1 antitrypsin deficiency (MZ phenotype). Am J Med 1977;62(1):93-8
   PubMed Web of Science ®Google Scholar
• Turino GM, Barker AF, Brantly ML, Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency: alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 1996;154(6 Pt 1):1718-25
   PubMed Web of Science ®Google Scholar
• Dahl M, Hersh CP, Ly NP, The protease inhibitor PI*S allele and COPD: a meta-analysis. Eur Respir J 2005;26(1):67-76
   PubMed Web of Science ®Google Scholar
• Dahl M, Tybjaerg-Hansen A, Lange P, Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 2002;136(4):270-9
   PubMed Web of Science ®Google Scholar
• Holme J, Stockley RA. CT Scan appearance, densitometry, and health status in protease inhibitor SZ alpha1-antitrypsin deficiency. Chest 2009;136(5):1284-90
   PubMed Web of Science ®Google Scholar
• Hill AT, Campbell EJ, Bayley DL, Evidence for excessive bronchial inflammation during an acute exacerbation of COPD in patients with alpha-1-antitrypsin deficiency. Am J Respir Crit Care Med 1999;160:1968-75
   PubMed Web of Science ®Google Scholar
• Sullivan A, Stockley RA. Proteinases and COPD. In: Hansel T, Barnes PJ, editors, Chronic obstructive pulmonary disease. Blackwell Publishing Ltd, Birkhauser, Boston, USA; 2007. p. 349-66
   Google Scholar
• Hartl D, Latzin P, Hordijk P, Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007;13(12):1423-30
   PubMed Web of Science ®Google Scholar
• Gadek JE, Klein HG, Holland PV, Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J Clin Invest 1981;68(5):1158-65
   PubMed Web of Science ®Google Scholar
• Schluchter MD, Stoller JK, Barker AF, Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 2000;161(3 Pt 1):796-801
   PubMed Web of Science ®Google Scholar
• Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 1998;158(1):49-59
   PubMed Web of Science ®Google Scholar
• Seersholm N, Wencker M, Banik N, Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J 1997;10(10):2260-3
   PubMed Web of Science ®Google Scholar
• Wencker M, Fuhrmann B, Banik N, Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest 2001;119(3):737-44
   PubMed Web of Science ®Google Scholar
• Chapman KR, Stockley RA, Dawkins C, Augmentation therapy for alpha-1 antitrypsin deficiency: a meta-analysis. J COPD 2009;6(3):177-84
   PubMedGoogle Scholar
• Gevenois PA, De Vuyst P, de Maertelaer V, Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996;154(1):187-92
   PubMed Web of Science ®Google Scholar
• Dowson LJ, Guest PJ, Hill SL, High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health status. Eur Respir J 2001;17:1097-104
   PubMed Web of Science ®Google Scholar
• Dawkins PA, Dowson LJ, Guest PJ, Predictors of mortality in alpha1-antitrypsin deficiency. Thorax 2003;58:1020-6
   PubMed Web of Science ®Google Scholar
• Dirksen A, Dijkman JH, Madsen F, A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999;160(5 Pt 1):1468-72
   PubMed Web of Science ®Google Scholar
• Dirksen A, Piitulainen E, Parr DG, Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Respir J 2009;33(6):1345-53
   PubMed Web of Science ®Google Scholar
• Parr DG, Dirksen A, Piitulainen E, Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency. Respir Res 2009;75:1-10
   Google Scholar
• Stockley RA, Deng C, Piitulainen E, Therapeutic efficacy of alpha-1 antitrypsin (AAT) augmentation therapy on the loss of lung tissue: an integrated analysis. Am J Respir Crit Care Med 2008;177(Suppl): abstract A419
   Google Scholar
• Luisetti M, Sturani C, Sella D, MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial. Eur Respir J 1996;9(7):1482-6
   PubMed Web of Science ®Google Scholar
• Stone PJ, Lucey EC, Snider GL. Induction and exacerbation of emphysema in hamsters with human neutrophil elastase inactivated reversibly by a peptide boronic acid. Am Rev Respir Dis 1990;141(1):47-52
   PubMed Web of Science ®Google Scholar
• Guarnieri F, Spencer JL, Lucey EC, A human surfactant peptide-elastase inhibitor construct as a treatment for emphysema. Proc Natl Acad Sci USA 2010;107(23):10661-6
   PubMed Web of Science ®Google Scholar
• Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med 1997;3(6):675-7
   PubMed Web of Science ®Google Scholar
• Belloni PN, Garvin L, Mao CP, Effects of all-trans-retinoic acid in promoting alveolar repair. Chest 2000;117(5 Suppl 1):235S-241S
   PubMed Web of Science ®Google Scholar
• Stockley RA, Stolk J. REPAIR (Retinoid treatment of Emphysema in Patients on the Alpha-antitrypsin International Registry Study results). Eur Respir J, Conference proceedings; 2009. p. 270s-271s
   Google Scholar
• Spencer LT, Humphries JE, Brantly ML. Antibody response to aerosolized transgenic human alpha1-antitrypsin. N Engl J Med 2005;352(19):2030-1
   PubMed Web of Science ®Google Scholar
• Pemberton PA, Kobayashi D, Wilk BJ, Inhaled recombinant alpha 1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. COPD 2006;3(2):101-8
   PubMedGoogle Scholar
• Brantly ML, Spencer LT, Humphries M, Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alpha l-antitrypsin (AAT) vector in AAT-deficient adults. Hum Gene Ther 2006;17(12):1177-86
   PubMed Web of Science ®Google Scholar
• McNab GL, Ahmad A, Mistry D, Modification of gene expression and increase in alpha1-antitrypsin (alpha1-AT) secretion after homologous recombination in alpha1-AT-deficient monocytes. Hum Gene Ther 2007;18:1171-7
   PubMed Web of Science ®Google Scholar
• Flotte TR, Brantly ML, Spencer LT, Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum Gene Ther 2004;15(1):93-128
   PubMed Web of Science ®Google Scholar
• Brantly ML, Spencer LT, Humphries M, Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. Hum Gene Ther 2006;17(12):1177-86
   PubMed Web of Science ®Google Scholar
• Burrows JA, Willis LK, Perlmutter DH. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci USA 2000;97(4):1796-801
   PubMed Web of Science ®Google Scholar
• Parfrey H, Dafforn TR, Belargey D, Inhibiting polymerization: new therapeutic strategies for Z alpha1-antitrypsin-related emphysema. Am J Respir Cell Mol Biol 2004;31(2):133-9
   PubMed Web of Science ®Google Scholar
• Mallya M, Phillips RL, Saldanha SA, Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates. J Med Chem 2007;50(22):5357-63
   PubMed Web of Science ®Google Scholar
• Stockley RA, Bayley DL, Unsal I, The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2002;165:1494-8
   PubMed Web of Science ®Google Scholar
• Needham M, Stockley RA. Exacerbations in alpha-1-antitrypsin deficiency. Eur Respir J 2005;25:992-1000
   PubMed Web of Science ®Google Scholar
• Lieberman J. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. Chest 2000;118(5):1480-5
   PubMed Web of Science ®Google Scholar
• Stockley RA, Luisetti M, Miravitlles M, Ongoing research in Europe: alpha one International Registry (AIR) objectives and development. Eur Respir J 2007;29:582-6
   PubMed Web of Science ®Google Scholar